Lonazolac

Lonazolac
Systematic (IUPAC) name

[3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl]acetic acid
Clinical data
Identifiers
ATC code	M01AB09
PubChem	CID 68706
ChemSpider	61957^N
UNII	13097143QI^Y
KEGG	D07265^Y
ChEBI	CHEBI:76164^N
Chemical data
Formula	C₁₇H₁₃Cl N₂O₂
Molecular mass	312.75032 g/mol
SMILES c1ccc(cc1)n2cc(c(n2)c3ccc(cc3)Cl)CC(=O)O
InChI InChI=1S/C17H13ClN2O2/c18-14-8-6-12(7-9-14)17-13(10-16(21)22)11-20(19-17)15-4-2-1-3-5-15/h1-9,11H,10H2,(H,21,22) ^N Key:XVUQHFRQHBLHQD-UHFFFAOYSA-N ^N
N (what is this?) (verify)

Lonazolac is a non-steroidal anti-inflammatory drug.

Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)

Acetic acid derivatives
and related substances

Propionic acid derivatives
(profens)

N-Arylanthranilic acids
(fenamates)

Other

Items listed in bold indicate initially developed compounds of specific groups. ^#WHO-EM ^†Withdrawn drugs. ^‡Veterinary use medications.

Index of muscle

Description	Anatomy head neck arms chest and back diaphragm abdomen genital area legs Muscle tissue Physiology connective tissue

Disease	Myopathy Soft tissue Connective tissue Congenital abdomen muscular dystrophy Neoplasms and cancer Injury Symptoms and signs eponymous

Treatment	Procedures Drugs anti-inflammatory muscle relaxants